Myeloablative T Cell-Depleted alloSCT With Early Sequential Prophylactic Donor Lymphocyte Infusion Is an Efficient and Safe Post-Remission Treatment for Adult ALL

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2013.184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Donor T-Lymphocyte Infusion for Unrelated Allogeneic Bone Marrow Transplantation With CD3+ T-Cell-Depleted Graft

Bone Marrow Transplantation
TransplantationHematology
2003English

B-Cell Enrichment and Infusion in CD4+/CD8+ T-Cell Depleted Products for Donor Innate Immune Lymphocyte Infusion: Is Risk of EBV-associated Lymphocyte Post Transplantation Lymphoproliferative Disease a Concern?

Bone Marrow Transplantation
TransplantationHematology
2008English

Donor Lymphocyte Infusions Induce Durable Responses in Patients With Follicular, Mantle and T Cell Lymphomas Relapsing After an Allosct. An Ebmt-LWP Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

T-Cell-Depleted Allogeneic Bone Marrow Transplantation Followed by Donor Lymphocyte Infusion in Patients With Multiple Myeloma: Induction of Graft-Versus-Myeloma Effect

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Characterization of T Cell Repertoire in Patients With Graft-Versus-Leukemia After Donor Lymphocyte Infusion.

Journal of Clinical Investigation
Medicine
1997English

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Comments on the Article ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic St

British Journal of Haematology
Hematology
2018English

Comments on the Article: ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic S

British Journal of Haematology
Hematology
2018English

Concurrent Use of Blinatumomab and Donor Lymphocyte Infusion (DLI) for Treatment of Relapsed Precursor B Cell Acute Lymphoblastic Leukemia (Pre B ALL) After Allogeneic Hematopoietic Cell Transplant (HCT)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy